Published peptide research references
Murepavadin
Governed registry record
4 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.
Approved source records
Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections.
DOI: 10.1128/cmr.00031-19PMID: 31462403
Source identity and connection checked by Codex (AI).
Murepavadin antimicrobial activity against and resistance development in cystic fibrosis Pseudomonas aeruginosa isolates.
Source identity and connection checked by Codex (AI).
Pharmacokinetics and Pharmacodynamics of Murepavadin in Neutropenic Mouse Models.
Source identity and connection checked by Codex (AI).
Unravelling the mechanisms causing murepavadin resistance in Pseudomonas aeruginosa: lipopolysaccharide alterations and its consequences.
DOI: 10.3389/fcimb.2024.1446626
Source identity and connection checked by Codex (AI).
Legacy research context
Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.
Researchers represented
- Hernández-García M
- Barbero-Herranz R
- Bastón-Paz N
- Díez-Aguilar M
- López-Collazo E
- Márquez-Garrido FJ
- Hernández-Pérez JM
- Baquero F
- Ekkelenkamp MB
- Fluit AC
- Fuentes-Valverde V
- Moscoso M
- Bou G
- Del Campo R
- Cantón R
- Avendaño-Ortiz J
- Melchers MJ
- Teague J
- Warn P
- Hansen J
- Bernardini F
- Wach A
- Obrecht D
- Dale GE
- Mouton JW
- Morosini MI
- Fluit A
- Tunney MM
- Huertas N
- Ekkelenkamp M
- Horcajada JP
- Montero M
- Oliver A
- Sorlí L
- Luque S
- Gómez-Zorrilla S
- Benito N
- Grau S